Erin Graves | Senior Director of Corporate Communications and Investor Relations |
Mark Goldsmith | Chairman, President & Chief Executive Officer |
Steve Kelsey | President of Research & Development |
Jack Anders | Chief Financial Officer |
Marc Frahm | TD Cowen |
Eric Joseph | JPMorgan Chase & Co. |
Michael Schmidt | Guggenheim Partners |
Benjamin Burnett | Stifel |
Jay Olson | Oppenheimer & Co. |
Ami Fadia | Needham & Company |
Jonathan Chang | SVB Securities |
Good day and welcome to Revolution Medicine's First Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded.
I would now like to turn the conference over to your host, Erin Graves, Senior Director of Corporate Communications and Investor Relations. Erin, please go ahead.
Thank you and welcome, everyone, to the first quarter 2023 earnings call.